Literature DB >> 10448086

Lipoamide dehydrogenase deficiency due to a novel mutation in the interface domain.

E Shany1, A Saada, D Landau, A Shaag, E Hershkovitz, O N Elpeleg.   

Abstract

An infant with a neurodegenerative disorder accompanied by lactic acidemia is described. In muscle homogenate, the activity of lipoamide dehydrogenase (LAD), the third catalytic subunit of pyruvate dehydrogenase complex (PDHc), alpha-ketoglutarate dehydrogenase complex (KGDHc), and branched-chain keto acid dehydrogenase complex was reduced to 15% of the control. The activity of PDHc was undetectable and the activity of KGDHc was 2% of the control mean. The immunoreactive LAD protein was reduced to about 10% of the control. Direct sequencing of LAD cDNA revealed only one mutation, substituting Asp for Val at position 479 of the precursor form. The mutation resides within the interface domain and likely perturbs stable dimerization. The phenotypic heterogeneity in LAD deficiency is not directly correlated with the residual LAD activity but rather with its impact on the multienzymatic complex activity. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448086     DOI: 10.1006/bbrc.1999.1133

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Mutations in the dimer interface of dihydrolipoamide dehydrogenase promote site-specific oxidative damages in yeast and human cells.

Authors:  Rachael A Vaubel; Pierre Rustin; Grazia Isaya
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

Review 2.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2011-10-07       Impact factor: 4.797

3.  Elevated plasma citrulline: look for dihydrolipoamide dehydrogenase deficiency.

Authors:  Ruby Haviv; Avraham Zeharia; Corinne Belaiche; Yishai Haimi Cohen; Ann Saada
Journal:  Eur J Pediatr       Date:  2013-08-31       Impact factor: 3.183

4.  Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex.

Authors:  Chad A Brautigam; R Max Wynn; Jacinta L Chuang; Mischa Machius; Diana R Tomchick; David T Chuang
Journal:  Structure       Date:  2006-01-26       Impact factor: 5.006

Review 5.  Advancements in the pathophysiology of Friedreich's Ataxia and new prospects for treatments.

Authors:  Ngolela E Babady; Nadege Carelle; Robert D Wells; Tracey A Rouault; Michio Hirano; David R Lynch; Martin B Delatycki; Robert B Wilson; Grazia Isaya; Hélène Puccio
Journal:  Mol Genet Metab       Date:  2007-06-26       Impact factor: 4.797

6.  The spectrum of pyruvate dehydrogenase complex deficiency: clinical, biochemical and genetic features in 371 patients.

Authors:  Kavi P Patel; Thomas W O'Brien; Sankarasubramon H Subramony; Jonathan Shuster; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2012-07       Impact factor: 4.797

7.  Leigh syndrome in a girl with a novel DLD mutation causing E3 deficiency.

Authors:  Shane C Quinonez; Steven M Leber; Donna M Martin; Jess G Thoene; Jirair K Bedoyan
Journal:  Pediatr Neurol       Date:  2013-01       Impact factor: 3.372

8.  Cryptic proteolytic activity of dihydrolipoamide dehydrogenase.

Authors:  Ngolela Esther Babady; Yuan-Ping Pang; Orly Elpeleg; Grazia Isaya
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

9.  Structural alterations induced by ten disease-causing mutations of human dihydrolipoamide dehydrogenase analyzed by hydrogen/deuterium-exchange mass spectrometry: Implications for the structural basis of E3 deficiency.

Authors:  Attila Ambrus; Junjie Wang; Reka Mizsei; Zsofia Zambo; Beata Torocsik; Frank Jordan; Vera Adam-Vizi
Journal:  Biochim Biophys Acta       Date:  2016-08-18

10.  Leigh syndrome due to compound heterozygosity of dihydrolipoamide dehydrogenase gene mutations. Description of the first E3 splice site mutation.

Authors:  Olga Grafakou; Konrad Oexle; Lambert van den Heuvel; Roel Smeets; Frans Trijbels; Hans H Goebel; Nils Bosshard; Andrea Superti-Furga; Beat Steinmann; Jan Smeitink
Journal:  Eur J Pediatr       Date:  2003-08-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.